Endocrine, Metabolic & Immune Disorders Drug Targets

Growth Hormone and Cancer Risk: A Two-Sample Bidirectional Mendelian Randomization Study with Mediation Testing

By Ze-Ming Yan, Yun-Zhi Zou, Yi-Guang Chen, De-Pei Li

Study in peopleMechanisms

The paper

Ze-Ming Yan, Yun-Zhi Zou, Yi-Guang Chen, De-Pei Li

Sun Yat-sen University Cancer Center

Endocrine, Metabolic & Immune Disorders Drug Targets, 1 Jan 2026

doi.org/10.2174/0118715303463853260710044412 PubMed 42565418

Medicine4 Oct 2026
Sex hormone-binding globulin raises lumbar fracture risk
IUBMB Life4 Oct 2026
Plasma asparagine links to lower cardioembolic stroke risk
Medicine2 Oct 2026
Genetically predicted TNF-beta protects against sarcopenia traits in humans
medRxiv4 Oct 2026
Plasma proteomics reveals pre-diagnostic markers for 25 cancers